ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

White Heads NIH Legislative Policy Office

March 5, 2010

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974

Price Increase

July 22, 1983

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014